The glutamate receptor subunit B (GluR-B) pre-mRNA is edited at two adenosine residues, resulting in amino acid changes that alter the electrophysiologic properties of the glutamate receptor. Previous studies showed that these amino acid changes are due to adenosine to inosine conversions in two codons resulting from adenosine deamination. Here, we describe the purification and characterization of an activity from human HeLa cells that efficiently and accurately edits GluR-B pre-mRNA at both of these sites. The purified activity contains a human homolog of the recently reported rat RED1 (rRED1) protein, a member of the family of double-stranded RNA-dependent deaminase proteins. Recombinant human RED1 (hRED1), but not recombinant dsRAD, another member of the family, efficiently edits both the Q͞R and R͞G sites of GluR-B RNA. We conclude that the GluR-B editing activity present in HeLa cell extracts and the recombinant hRED1 protein are indistinguishable.
RNA editing is a novel mechanism for generating distinct protein isoforms from a single pre-mRNA (1) (2) (3) . Pre-mRNA encoding the B subunit of the glutamate receptor (GluR-B) undergoes site specific deamination (4) (5) (6) at an adenosine residue in the second transmembrane domain. This results in the transformation of a glutamate codon (CAG) to an arginine codon (CIG) (designated the Q͞R site) (7) (8) (9) (10) (11) . This amino acid substitution profoundly alters the ion permeability and conductance properties of the class of ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-responsive receptor channels in the brain that contain a GluR-B subunit (1, (12) (13) . More than 99% of the GluR-B mRNA is edited at the Q͞R site in adult neurons (8) (9) . Adenosine conversions are also observed at the same position of the high-affinity kainate receptor subunits GluR-5 and GluR-6 with efficiencies of 40% and 80%, respectively (8) . In addition to the Q͞R site, RNA adenosine deamination occurs in exon 13 of GluR-B, C, and D pre-mRNAs, where an arginine codon (AGA) is converted to a glycine codon (IGA) (designated the R͞G site) (14) (15) .
Editing of both the Q͞R and R͞G site requires base pairing between the editing site and an editing site complementary sequence (ECS) within the downstream intron (10) . The requirement for RNA duplex formation at the editing site in GluR-B was demonstrated by showing that base substitutions that disrupt the potential for base pairing interactions block editing. Moreover, these mutants can be rescued in vivo and in vitro by second site mutations that reestablish base pairing (4, 10) . These observations suggested that a double-stranded (ds)RNA adenosine deaminase activity may be involved in GluR-B editing. Two dsRNA-dependent adenosine deaminases have been described in vertebrates: dsRAD and RED1. In vitro, recombinant RED1 accurately and efficiently edits GluR-B at the Q͞R site (16) . In contrast, recombinant dsRAD is capable of only low levels of GluR-B editing at the Q͞R site (17) (18) , but converts A to I at sites that are not observed in vivo. These experiments with purified recombinant proteins suggest that RED1 is responsible for editing GluR-B RNA in vivo.
We have previously developed an in vitro system in which extracts of HeLa cells accurately and efficiently edit the Q͞R site of GluR-B (4) . In this study, we provide independent evidence that the GluR-B editing activity is indeed mediated by RED1. We have fractionated HeLa extracts into two dsRNA-dependent adenosine deaminase activities. One activity, identified as human dsRAD, converts A to I in dsRNA nonspecifically and lacks specific GluR-B editing activity at the Q͞R site. A second deaminase activity, identified as hRED1, specifically edits GluR-B RNA at the Q͞R and R͞G sites. Moreover, we have expressed the cloned hRED1 in a baculovirus expression system, and we demonstrate that this enzyme efficiently edits GluR-B pre-mRNA at both the Q͞R and R͞G sites, and is thus indistinguishable from the activity in HeLa cell nuclear extracts. The recombinant RED1 was also used to characterize the RNA sequence requirements for editing at the R͞G site. Our results suggest that editing at both the Q͞R and R͞G sites could result from the activity of a single enzyme, RED1.
MATERIALS AND METHODS
Materials. HeLa cells were purchased from the National Cell Culture Center (Minneapolis). Heparin Sepharose, Q Sepharose, phenyl-superose, and Mono Q HR 5͞5 columns were purchased from Pharmacia. RNase P1 and adenylyl guanosine dinucleotide (ApG) were purchased from Sigma. Protein quantitation was done with a Bio-Rad protein assay kit. All oligonucleotides used for mutagenesis and cloning were made commercially (Operon Technologies, Alameda, CA; and Oligo Synthesis at Tufts, Boston).
Preparation of Nuclear Extract for Editing. Nuclear extract for RNA editing was prepared as follows: A cell pellet from 100 l HeLa cells was quickly washed once and resuspended in wash buffer (10 mM Hepes, pH 7.9͞1.5 mM MgCl 2 ͞10 mM KCl͞0.5 mM dithiothreitol). Cells were lysed with a Dounce homogenizer, centrifuged at 3,000 ϫ g for 15 min and the nuclear pellet was resuspended in one volume of low salt buffer (20 mM Tris⅐HCl͞25% glycerol͞1.5 mM MgCl 2 ͞15 mM KCl). One volume of high salt buffer (20 mM Tris⅐HCl͞25% glycerol͞1.5 mM MgCl 2 ͞1.2 M KCl) was then slowly added over 20 min and stirred slowly for 30 min. After centrifugation at 10,000 ϫ g for 30 min, the supernatant was dialyzed against 10 volumes of editing buffer (20 mM Hepes, pH 8.0͞100 mM KCl͞5 mM dithiothreitol͞10 mM EDTA͞20% glycerol͞0.5% Nonidet P-40). The nuclear extract was then precipitated with 20% saturated (NH 4 ) 2 SO 4 and the supernatant was precipitated with 45% saturated (NH 4 ) 2 SO 4 . The 45% pellet then was resuspended in 100 ml of editing buffer and dialyzed against the same buffer. Aliquots were frozen at ⅐80ЊC. Editing was assayed as previously described using the 5Ј-end-labeled 3Ј-half GluR-B Q͞R site RNA or the uniformly labeled ds ␣-tropomyosin exon 2 RNA (4).
Chromatography. A 10-ml heparin Sepharose column (Pharmacia) was packed and equilibrated with buffer A (10 mM Hepes͞50 mM KCl/5 mM EDTA͞0.5 mM dithiothreitol). Twenty-five milliliters of HeLa nuclear extract was thawed, loaded onto the column and washed with the same buffer until OD 280 reached baseline. The bound proteins were then eluted with a gradient of buffer B (buffer A ϩ 1 M NaCl) to 100% in 30 ml, followed by a 30 ml wash with buffer B. The eluate fractions were collected and dialyzed individually against editing buffer. GluR-B RNA editing activity and dsRAD activity were independently assayed and the active fractions were pooled. These fractions were then chromatographed on a 5 ml Q Sepharose column followed by a 2 ml GluR-B RNA affinity column, as described for the heparin column. For the Q Sepharose column, the salt gradient was from 50 mM to 1M NaCl in 15 ml. For the GluR-B RNA affinity column, the gradient was from 50 mM to 3M KCl in 10 ml. Chromatography on the last hydrophobic column (5 ml of phenyl superose) was carried out by loading the active fractions in the high salt buffer [buffer A ϩ 1 M NaCl ϩ 0.5 M (NH 4 ) 2 SO 4 ] and eluting with decreasing concentrations of buffer A to 0% in 15 ml volume. All chromatography was done at 4ЊC. Active fractions were aliquoted and stored at Ϫ80ЊC.
Western Blot Analysis. Recombinant His-tagged rRED1 was purified by nickel affinity chromatography according to the manufacturer's protocol (Invitrogen) and used to raise antibodies in mice. Purified fractions from HeLa cells were separated on one-or two-dimensional gels, transferred to nitrocellulose membranes and blotted with antiserum (BioRad).
Reverse Transcription-PCR, Cloning, and Sequencing. Total RNA from HeLa cells was isolated using RNAzol (TelTest, Friendswood, TX) and mRNA was enriched using the PolyA Tract system (Promega). Reverse transcription and ''nested'' PCR reactions were performed using Vent DNA polymerase with degenerate primers (atg-n, ATGGATATN-GANGANGANGANAANA; tga-n, TCANGGNGTNANN-GANAANTG) and primers (up-n, GANAANATGAGTTCC-AGCAGCA; down-n, GTCCTGCTCTGTGGGCTTCTCCA-CCCAGG). The amplified bands were purified from the agarose gel and cloned into pGEM7 at the SmaI site. To determine the sequence, the insert was deleted from the 5Ј and 3Ј ends using the Erase-a-Base system (Promega) and sequenced by dideoxy methods.
Expression of Recombinant Proteins in Insect Cells. The human and rat RED1 cDNAs were subcloned into pFastBacHTb and proteins were expressed in Sf9 cells (GIBCO͞BRL). Proteins were purified by nickel column chromatography under native conditions (Invitrogen). The purified protein was Ͼ95% pure as determined by electrophoresis on an 8% SDS gel. One ml of the protein was dialyzed against PBS and the concentration was determined. The editing activities were determined as described (4) . For the quick assay, the transfected cells were harvested, sonicated in editing buffer and centrifuged. The supernatant was then used without further purification to assay editing activity. Converted RNA was quantitated using the Fuji imaging system.
In Vitro Mutagenesis. Mutagenesis in GluR-B RNA substrates was made by in vitro T7 transcription using PCRgenerated DNA templates. RNA labeled specifically at the R͞G site was made by RNA ligation as described (4). UV Crosslinking. The site specifically labeled GluR-B RNA (Q͞R site) was mixed with the purified fraction and incubated for 5 min under editing conditions (4) . The samples were put on ice and irradiated under 300 nm UV light for 10 min. The sample was resolved by SDS͞PAGE (10% gel) and the crosslinked bands were visualized using the Fuji imaging system.
RESULTS
Separation of Two Distinct Adenosine Deaminase Activities from HeLa Cells. We wished to identify the ds adenosine deaminase activity responsible for GluR-B editing in HeLa cell nuclear extracts. Two assays were employed to monitor adenosine deaminase activity, one which monitors site specific editing of GluR-B, and the other which detects nonspecific A to I conversion. In the first assay an RNA containing the Q͞R site of GluR-B and the downstream ECS was labeled with 32 P exclusively at the editing site as described (4) . After incubation with the chromatographic fractions, the labeled RNA was digested with nuclease P1 and the products were separated by thin layer chromatography. Adenosine deaminase activity was demonstrated by the appearance of 32 P-labeled inosine monophosphate. In the second assay, which detects nonspecific dsRNA editing, dsRNA was uniformly labeled with 32 P, incubated with the sample and analyzed for A to I conversion as described above.
A 20-45% ammonium sulfate precipitate of the HeLa cell nuclear extract was fractionated on a heparin Sepharose affinity column and most of the dsRNA deaminase activity was recovered in the 0.5 M NaCl fractions, while the site-specific editing activity eluted at 0.9 M NaCl (Fig. 1A) . When the fractions were analyzed by Western blot analysis using an anti-dsRAD antibody, a band of the expected molecular weight (140 kDa) was observed in the first peak (data not shown). The fractions in the second peak were pooled and chromatographed on a Q Sepharose column. The GluR-B RNA editing activity was found in a relatively sharp peak, whereas the dsRNA deaminase activity was present at low levels in the flow-through fractions and in fractions eluted at lower salt concentrations (Fig. 1B ). The active fractions were then loaded onto a phenyl Sepharose hydrophobic interaction column and eluted with decreasing concentrations of NaCl. The editing activity was eluted at low concentrations of NaCl (Fig. 1C) .
UV crosslinking experiments with the active phenyl Sepharose fractions and Q͞R site-labeled GluR-B RNA revealed a strong band of 90 kDa and less intense bands of 140 and 100 kDa ( Fig. 2A, lane 1) . The 90-kDa protein could also be visualized by silver staining (Fig. 2 A, lane 2) . Western blot experiments using a polyclonal anti-rat RED1 antiserum (Fig.  2 A, lanes 3-5, and B) reveal a 90-kDa band demonstrating that RED1 was present in the active fractions. Thus the two adenosine deaminase activities can be chromatographically separated into one that specifically edits GluR-B and contains the 90-kDa protein RED1, and a second activity that nonspecifically deaminates dsRNA and contains the 140 kDa dsRAD.
Characterization of Recombinant hRED1. To characterize the properties of RED1 and compare them with the properties found in our HeLa cell extracts, we cloned the hRED1 cDNA from HeLa cell RNA by RT-PCR using two pairs of degenerate primers derived from the rRED1 sequence (10) . One of the cloned cDNA sequence matches the Homo sapiens mRNA sequence deposited previously by Mittaz et al. in GenBank (accession no. X99383) which is 86% homologous to rRED1 at the nucleic acid sequence level. Recombinant human and rat RED1 were synthesized and expressed in insect cells using the baculovirus expression system. A full-length protein of apparent molecular mass of 95 kDa was produced and purified on a nickel affinity column. The purified recombinant hRED1 edits GluR-B RNA efficiently at the Q͞R site, and the kinetics of the reaction are identical to that of the rRED1 protein (Fig.  3A) . Comparison of the purified HeLa cell activity and recombinant human and rat RED1 proteins reveals that the substrate specificities of the two deaminase activities are virtually indistinguishable (Fig. 3B) . The ratio of the GluR-B editing and dsRNA deaminase activities is Ϸ80:1. By contrast, at concentrations of dsRAD at which maximal levels of activity with dsRNA are observed, no GluR-B editing activity is detected (Fig. 3B, panel 4) . Taken together, these observations strongly support the conclusion that the editing activity in the purified fractions from HeLa nuclear extracts is due entirely to the presence of hRED1 and that the human and rat RED1 proteins have a different substrate selectivity compared with dsRAD.
Substrate Requirements for RED1 Proteins. The RNA sequence and secondary structure of the GluR-B R͞G site differs from the Q͞R site. To investigate whether RED1 protein specifically edits the GluR-B R͞G site, we determined the substrate requirements for RNA editing at the R͞G site by recombinant rRED1. A 99-nucleotide RNA containing the R͞G site, with 21 nucleotides upstream of the edited nucleotide and 78 nucleotides downstream (Fig. 4A) , is edited efficiently by recombinant rRED1 (Fig. 4B, lanes 3 and 4) . Previously, we demonstrated that RNA sequences immediately upstream from the edited adenosine residue at the Q͞R site of GluR-B RNA are not required for editing (4) . Interestingly, like the Q͞R site, the nucleotides immediately upstream from the adenosine residue at the R͞G site are not required for editing by the RED1 protein (Fig. 4B, ⌬5ЈUp,  lanes 5 and 6) . Similarly, the sequence downstream of the ECS is not required for R͞G site in vitro editing by RED1 (Fig. 4B,  ⌬5ЈUp ϩ ⌬3ЈDown, lanes 7 and 8) . Thus an RNA of only 58 nucleotides, containing the editing site and an imperfect RNA stem structure, is sufficient for accurate R͞G site editing.
To begin to understand the extent of the specificity of RED1 for the R͞G site, we examined the effects of selected single base substitutions in areas of imperfect RNA duplex formation on in vitro editing with the rRED1 protein. Within the area of apparent RNA duplex, the minimal R͞G site RNA contains an A-C mismatch at position 11 (A 11 C 47 ) and G-G mismatch at position 15 (G 15 G 43 ). Interestingly, the Q͞R site RNA can form a similar structure near the editing site with mismatches at positions 13 (A 13 C 309 ) and 20 (G 20 A 302 ) (Fig. 5) . Substitution of A 11 of the R͞G editing substrate or A 13 of the Q͞R substrate by a G had no effect on the in vitro editing activity, even though these mutations should stabilize the RNA stem structure by forming an additional base pair interaction. By contrast, when C 47 of the R͞G site or C 309 of the Q͞R site was changed to U, the efficiency of editing was reduced 2-to 3-fold. These mutations should also increase the stability of the RNA stem; however, they decrease the efficiency of editing, implying that base pairing at this position is not required for efficient editing. Rather, the editing activity displays a preference for specific sequence elements, preferring C to U at position 47 independent of base pairing. Double mutations in the R͞G site RNA (C 47 to U and G 43 to C) that should result in a perfect RNA stem structure dramatically reduced the editing efficiency (40-fold). Similarly, double mutations at the corresponding sites in the Q͞R site RNA (C 309 to U and A 302 to C) also reduced the efficiency of editing, in this case by Ϸ20-fold (Fig.  5A) . Although the Q͞R and R͞G sites share a number of structural similarities, a difference occurs at the edited nucleotide. In the Q͞R site this nucleotide is base-paired with its complement in the ECS, while at the R͞G site there is a mismatch. This base pairing is not important for efficient Q͞R editing in vivo (19) . To investigate the role of this mismatch at the minimal R͞G editing site, we synthesized an RNA with a C to U base substitution at position 57 in the R͞G substrate. This substitution creates a base pair at the editing site, but had no significant effect on editing efficiency by rRED1 (A 1 U 57 in Fig. 5B ). Thus, for the end-labeled GluR-B substrate, base pairing at the R͞G or Q͞R editing sites is not required for efficient editing in vitro.
DISCUSSION
The GluR-B subunit of the mammalian glutamate receptor undergoes RNA editing at two specific adenosines that results in amino acid substitutions that profoundly alter the conductance properties of the ion channel (1, (12) (13) . A mutational analysis of the sequence determinants essential for efficient editing at the Q͞R site demonstrated the requirement for RNA base pairing surrounding the editing site (4, 10) . These data suggested that dsRAD might be responsible for the 1, 2) . The minimal R͞G site RNA (R͞G, lanes 3 and 4) was made by RNA ligation of unlabeled 21 mer RNA (pppGGACCUAAAGGAUCCUCAUUA) and 5Ј end-labeled 78 mer RNA lacking the 5ЈUp sequence (⌬5ЈUp). Deletion of 5ЈUp (⌬5ЈUp, lanes 5 and 6) and deletion of 5ЈUp and 3ЈDown (⌬5Ј ϩ ⌬3Ј, lanes 7 and 8) were made by in vitro transcription based on PCR-generated templates. The adenosine at the editing site was added by ApG dinucleotide during transcription and labeled using T4 polynucleotide kinase. deamination of two specific adenosines in GluR-B premRNAs (19) . Our data, taken together with work from other labs (17) (18) (19) , indicates that neither purified nor recombinant dsRAD is sufficient for accurate and efficient GluR-B editing at the Q͞R site in vitro. However, these data could not exclude the possibility that dsRAD is responsible for GluR-B editing in vivo, but requires the presence of one or more cofactors that enhance the efficiency and specificity of editing (4, 17) .
More recently, a second adenosine deaminase activity, RED1, was identified that shares significant homology with dsRAD. Recombinant RED1 can accurately and efficiently edit the Q͞R site of GluR-B pre-mRNA in vitro (16) . In this study, we provide independent evidence that GluR-B editing activity in vivo is mediated by RED1. We show that two distinct dsRNA-dependent adenosine deaminase activities in HeLa cell nuclear extracts can be separated by chromatography. One fraction reveals a nonspecific dsRNA adenosine deaminase activity, lacks specific GluR-B editing activity and contains dsRAD. The other HeLa cell activity specifically edits GluR-B Q͞R RNA and contains RED1. We have cloned the hRED1 gene and expressed the hRED1 protein in a baculovirus system. The recombinant protein exhibits specific GluR-B editing at the Q͞R and R͞G sites and mimics the activity observed in extracts, suggesting that the RED1 protein alone can mediate efficient and specific GluR-B editing. Although the minimal R͞G substrate (Fig.  4 A) is not edited by dsRAD (data not shown), both RED1 and dsRAD can edit full length R͞G site substrates with comparable efficiencies (16) . Thus, we cannot rule out the possibility that the R͞G site in GluR-B is edited by distinct deaminases in vivo.
We have also determined the substrate requirements for editing at the R͞G site and compared these with the determinants of editing at the Q͞R site. In initial experiments, we demonstrated that an RNA of only 58 nucleotides containing the R͞G editing site and an imperfect RNA stem structure are sufficient for accurate R͞G site editing. We found that editing prefers a C at position 47 for efficient editing, regardless of whether base pairing occurs at this position. Substitution of this C by a U in conjunction with a substitution of G 43 with C creates a perfect duplex stem. This observation implies that dsRNA binding is not sufficient for site-specific editing. Rather, additional features such as specific sequences or mispaired nucleotides may be required. However, we do not know whether the loss of editing activity observed with the G 43 mutation is a consequence of the loss of the mismatch at this position or the base substitution.
Finally, the widespread expression of both dsRAD and RED1 suggests that additional pre-mRNA substrates for these deaminase activities remain to be determined. HeLa cells, for example, express RED1 activity but do not express the glutamate receptor subunits. Identification of additional pre-mRNA substrates for these deaminase activities will provide additional insight into the mechanisms of RNA editing and the role of this process in regulating the differential expression of the protein isoforms that derive from edited and unedited mRNAs.
